These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36470050)

  • 41. A USA-based registry for pulmonary arterial hypertension: 1982-2006.
    Thenappan T; Shah SJ; Rich S; Gomberg-Maitland M
    Eur Respir J; 2007 Dec; 30(6):1103-10. PubMed ID: 17804449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Evolution of Risk Assessment in Pulmonary Arterial Hypertension.
    Murthy S; Benza R
    Methodist Debakey Cardiovasc J; 2021; 17(2):134-144. PubMed ID: 34326933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of ongoing trials in exercise based rehabilitation for pulmonary arterial hypertension.
    Babu AS; Padmakumar R; Maiya AG
    Indian J Med Res; 2013 May; 137(5):900-6. PubMed ID: 23760374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics.
    Badlam JB; Badesch DB; Austin ED; Benza RL; Chung WK; Farber HW; Feldkircher K; Frost AE; Poms AD; Lutz KA; Pauciulo MW; Yu C; Nichols WC; Elliott CG;
    Chest; 2021 Jan; 159(1):311-327. PubMed ID: 32858008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. End-of-Life Palliative Care Practices and Referrals in Uganda.
    Low D; Merkel EC; Menon M; Loggers E; Ddungu H; Leng M; Namukwaya E; Casper C
    J Palliat Med; 2018 Mar; 21(3):328-334. PubMed ID: 29058504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation.
    Jansen K; Constantine A; Condliffe R; Tulloh R; Clift P; Moledina S; Wort SJ; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):837-855. PubMed ID: 34511015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of COVID-19 pandemic on the management of pulmonary hypertension.
    Zhou CY; Sahay S; Shlobin O; Soto FJ; Mathai SC; Melendres-Groves L; Mullin CJ; Levine DJ; Kay D; Highland K; Bossone E; Poms A; Memon H; Balasubramanian V; Farmer MJS; Rahaghi F; Elwing JM
    Respir Med; 2023 Jan; 206():107061. PubMed ID: 36493604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P
    Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care.
    Hausner D; Tricou C; Mathews J; Wadhwa D; Pope A; Swami N; Hannon B; Rodin G; Krzyzanowska MK; Le LW; Zimmermann C
    Oncologist; 2021 Apr; 26(4):332-340. PubMed ID: 33284483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.
    Gu S; Hu H; Dong H
    Pharmacoeconomics; 2016 Aug; 34(8):751-70. PubMed ID: 26951248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension.
    Matura LA; McDonough A; Hanlon AL; Carroll DL; Riegel B
    Eur J Cardiovasc Nurs; 2015 Oct; 14(5):423-30. PubMed ID: 24867878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease.
    Shinall MC; Karlekar M; Martin S; Gatto CL; Misra S; Chung CY; Porayko MK; Scanga AE; Schneider NJ; Ely EW; Pulley JM; Jerome RN; Dear ML; Conway D; Buie R; Liu D; Lindsell CJ; Bernard GR
    J Pain Symptom Manage; 2019 Oct; 58(4):614-622.e3. PubMed ID: 31276810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary arterial hypertension: epidemiology and registries.
    McGoon MD; Benza RL; Escribano-Subias P; Jiang X; Miller DP; Peacock AJ; Pepke-Zaba J; Pulido T; Rich S; Rosenkranz S; Suissa S; Humbert M
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D51-9. PubMed ID: 24355642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries.
    Khanna D; Zhao C; Saggar R; Mathai SC; Chung L; Coghlan JG; Shah M; Hartney J; McLaughlin V
    Arthritis Rheumatol; 2021 May; 73(5):837-847. PubMed ID: 33538058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sildenafil for Pulmonary Arterial Hypertension.
    Bhogal S; Khraisha O; Al Madani M; Treece J; Baumrucker SJ; Paul TK
    Am J Ther; 2019; 26(4):e520-e526. PubMed ID: 30946047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.
    Wozencraft CP; Coyne PJ; Grinnan DC; Morel TD; Muzevich KM; Smith TJ
    J Palliat Med; 2012 May; 15(5):619-22. PubMed ID: 22394366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.